Thermo Fisher Prices $1B of Senior Notes | GenomeWeb

NEW YORK (GenomeWeb) – Thermo Fisher Scientific announced after the close of the market on Monday that it has priced $1 billion of senior notes.

The Waltham, Massachusetts-based scientific products giant's 3 percent senior notes are paid on a semi-annual basis, and are due in 2023. The issue price is 99.512 percent of the principal amount.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.